Be the first to know

Never miss an update from CSL. Did you know that during reporting season, the announcements from ASX:CSL often move the market?

CSL (ASX:CSL) Company Logo

By joining StockLight, you agree to our Terms & Conditions and Privacy Policy
Create Alert Follow CSL

CSL (CSL)

AU ASX:CSL (133.6B)

285.33
-8.65 (-3.03%)
4pm Friday Jun 05 AEST
LOADING
Loading price chart..

Summary

Current Price: $285.33
52w High/Low: $200.37 - 342.75
Market Cap: 133.6B
Price/Earnings: 46.42
Dividend Yield: 0.99%
Volume/Average: 1.8M - $933
CSL (ASX:CSL) Company Logo

Listed in 1994

Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.
CSL (ASX:CSL) Company Logo

Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.

Annual Reports

CSL Annual Report 2018/19 Sep 5th 2019
2019
(6.8mb)
CSL Annual Report to shareholders Sep 13th 2018
2018
(5.8mb)
Annual Report to Shareholders Sep 14th 2017
2017
(5.8mb)
Annual Report to shareholders Sep 8th 2016
2016
(5.5mb)
Annual Report to shareholders Sep 11th 2015
2015
(4.3mb)

Dividend History

Quantitative Ratios

Stock Ratios Locked
You viewed 3 companies today
Ratios will be unlocked
again tomorrow or;

Unlock these ratios,
configure alerts
and much more...

Download StockLight

All Ratios, Alerts and other features are available in our iOS and Android apps:
Download on iOS Download on Android

We are working on updating this web app to fully enable Quantitative Ratios. All other current web features including annual reports, price sensitive announcements, dividends and earnings transcripts are free to use here on our web app.
Dividend Yield
0.3%
 
1.0%
 
 
Industry Avg
CSL

ATTRACTIVE: CSL's dividend yield of 1.0% exceeds the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more
Implied Growth
33.1%
 
7.8%
 
 
Industry Avg
CSL

ATTRACTIVE: CSL exhibits an implied growth ratio which is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. CSL calculation: 10% - ($6.32 / $285.33) = 7.8% more
Price / Book
4.8
 
15.4
 
 
Industry Avg
CSL

UNATTRACTIVE: CSL exhibits a price/book ratio which exceeds the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more
Price / Earnings
19.8
 
46.5
 
 
Industry Avg
CSL

UNATTRACTIVE: CSL's price/earnings ratio of 46.5 exceeds the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more
Price / Sales
18.0
 
10.5
 
 
Industry Avg
CSL

ATTRACTIVE: CSL exhibits a price/sales ratio which is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more

Company News

What the 10 largest companies in the world have in common
June 5th, 2020 - Motley Fool

Here's what the 10 largest companies in the world all have in common – and what ASX inevstors can learn from their dominance. The post What the 10 largest companies in the world have in common appeared first on Motley Fool Australia.

Why is it so hard to outperform the ASX 200 index?
June 5th, 2020 - Motley Fool

Here's why it's so hard for ASX investors to outperform the ASX 200 index over time. But never fear, it can be done! The post Why is it so hard to outperform the ASX 200 index? appeared first on Motley Fool Australia.

CSL share price lower despite COVID-19 vaccine news
June 5th, 2020 - Motley Fool

The CSL Limited (ASX:CSL) share price is dropping lower on Friday after releasing an update on its COVID-19 vaccine plans... The post CSL share price lower despite COVID-19 vaccine news appeared first on Motley Fool Australia.

Brokers name 3 ASX shares to buy today
June 5th, 2020 - Motley Fool

Brokers have named CSL Limited (ASX:CSL) and these ASX shares as buys. Here's why they are tipping their shares to shoot higher from here... The post Brokers name 3 ASX shares to buy today appeared first on Motley Fool Australia.

2 ASX growth shares I'd buy before Afterpay shares
June 5th, 2020 - Motley Fool

With a market cap of ~$13 billion the Afterpay share is unlikely to grow another ten times. But these two growth shares just might. The post 2 ASX growth shares I’d buy before Afterpay shares appeared first on Motley Fool Australia.

Why Appen, CSL, Openpay, & Zip Co shares are tumbling lower
June 5th, 2020 - Motley Fool

Appen Ltd (ASX:APX) and CSL Limited (ASX:CSL) are two of four shares tumbling lower on Friday. Here's why they are down in the dumps today... The post Why Appen, CSL, Openpay, & Zip Co shares are tumbling lower appeared first on Motley Fool Australia.

The 10 shares that significantly move the ASX 200 index
June 4th, 2020 - Motley Fool

Here's why some shares like CSL Limited (ASX: CSL) have far more power within the ASX 200 Index than others The post The 10 shares that significantly move the ASX 200 index appeared first on Motley Fool Australia.

3 top ETFs you can easily diversify your portfolio with immediately
June 4th, 2020 - Motley Fool

Are you wanting to diversify your portfolio? The buying BetaShares NASDAQ 100 ETF (ASX:NDQ) and these top ETFs would be an easy way to do it. The post 3 top ETFs you can easily diversify your portfolio with immediately appeared first on Motley Fool Australia.